Inhibition of tumor necrosis factor-α induced neutrophil apoptosis by cyclic AMP: Involvement of caspase cascade

European Journal of Pharmacology

Volumn 371, Issue 1, 1999, Pages 59-67

  Niwa, Masayuki ^a   Hara, Akira ^a   Kanamori, Yutaka ^a   Matsuno, Hiroyuki ^a   Kozawa, Osamu ^a   Yoshimi, Naoki ^a   Mori, Hideki ^a   Uematsu, Toshihiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Blood neutrophil; cAMP; Caspase; Cycloheximide; Human; TNF (tumor necrosis factor )

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; BUCLADESINE; CASPASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOHEXIMIDE; FORSKOLIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL;

4-(3-BUTOXY-4-METHOXYBENZYL)-2-IMIDAZOLIDINONE; APOPTOSIS; BUCLADESINE; CASPASES; CYCLIC AMP; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FORSKOLIN; HUMANS; NEUTROPHILS; PROTEIN KINASE C; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033007052     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00145-4     Document Type: Article

References (58)

1. Aharoni D., Dantes A., Oren M., Amsterdam A. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells. Exp. Cell Res. 218:1995;271-282.
2. Albina J.E., Cui S., Mateo R.B., Reichner J.S. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150:1993;5080-5085.
3. Al-Essa L.Y., Niwa M., Kohno K., Nozaki M., Tsurumi K. Heterogeneity of circulating and exudated polymorphonuclear leukocytes in superoxide-generating response to cyclic AMP and cyclic AMP-elevating agents: Investigation of the underlying mechanism. Biochem. Pharmacol. 49:1995;315-322.
4. Aoshiba K., Nagai A., Konno K. Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob. Agents Chemothr. 39:1995;872-877.
5. Beauvais F., Michel L., Dubertret L. The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils. FEBS Lett. 361:1995;229-232.
6. Begley C.G., Lopez A.F., Nicola N.A., Warren D.J., Vadas M.A., Sanderson C.J., Metcalf D. Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. Blood. 68:1986;162-166.
7. Bohlinger I., Leist M., Barsig J., Uhlig S., Tiegs G., Wendel A. Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways. Hepatology. 22:1995;1829-1837.
8. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:1996;803-815.
9. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 97:1968;77-89.
10. Chang J.Y., Korolev V.V., Wang J.Z. Cyclic AMP and pituitary adenylate cyclase-activating polypeptide (PACAP) prevent programmed cell death of cultured rat cerebellar granule cells. Neurosci. Lett. 206:1996;181-184.
11. Chun S.Y., Eisenhauer K.M., Kubo M., Hsueh A.J. Interleukin-1 beta suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production. Endocrinology. 136:1995;3120-3127.
12. Fehsel K., Kroncke K.D., Meyer K.L., Huber H., Wahn V., Kolb-Bachofen V. Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol. 155:1995;2858-2865.
13. Genaro A.M., Hortelano S., Alvarez A., Martinez C., Bosca L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J. Clin. Invest. 95:1995;1884-1890.
14. Gjertsen B.T., Cressey L.I., Ruchaud S., Houge G., Lanotte M., Doskeland S.O. Multiple apoptotic death types triggered through activation of separate pathways by cAMP and inhibitors of protein phosphatases in one (IPC leukemia cell line). J. Cell Sci. 107:1994;3363-3377.
15. Grigg J.M., Savill J.S., Sarraf C., Haslett C., Silverman M. Neutrophil apoptosis and clearance from neonatal lungs. Lancet. 338(8769):1991;720-722.
16. Hallsworth M., Giembycz M.A., Barnes P.J., Lee T.H. Cyclic AMP-elevating agents prolong or prior exposure to GM-CSF. Br. J. Pharmacol. 117:1996;79-86.
17. Harvath L., Robbins J.D., Russell A.A., Seamon K.B. cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness. J. Immunol. 146:1991;224-232.
18. Hoshi S., Furutani-Seiki M., Seto M., Tada T., Asano Y. Prevention of TCR-mediated apoptosis by the elevation of cyclic AMP. Int. Immunol. 6:1994;1081-1089.
19. Ignarro L.J., George W.J. Mediation of immunologic discharge of lysosomal enzymes from human neutrophils by guanosine 3′, 5′-monophosphate. Requirement of calcium, and inhibition by adenosine 3′, 5′-monophosphate. J. Exp. Med. 140:1974;225-238.
20. Kiefer J., Okret S., Jondal M., McConkey D.J. Functional glucocorticoid receptor expression is required for cAMP-mediated apoptosis in a human leukemic T cell line. J. Immunol. 155:1995;4525-4528.
21. Kizaki H., Nakada S., Ohnishi Y., Azuma Y., Mizuno Y., Tadakuma T. Tumour necrosis factor-alpha enhances cAMP-induced programmed cell death in mouse thymocytes. Cytokine. 5:1993;342-347.
22. Klebanoff S.J., Vadas M.A., Harlan J.M., Sparks L.H., Gamble J.R., Agosti J.M., Waltersdorph A.M. Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136:1986;4220-4225.
23. 2+ by cAMP in vascular smooth muscle cells. Am. J. Physiol. 258:1990;C399-407.
24. Lomo J., Blomhoff H.K., Beiske K., Stokke T., Smeland E.B. TGF-beta 1 and cAMP promote apoptosis in resting human B lymphocytes. J. Immunol. 154:1995;1634-1643.
25. Lopez A.F., Williamson D.J., Gamble J.R., Begley C.G., Harlan J.M., Klebanoff S.J., Waltersdorph A., Wong G., Clark S.C., Vadas M.A. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J. Clin. Invest. 78:1986;1220-1228.
26. Machleidt T., Kramer B., Adam D., Neumann B., Schutze S., Wiegmann K., Kronke M. Function of the p55 tumor necrosis factor receptor 'death domain' mediated by phosphatidylcholine-specific phospholipase C. J. Exp. Med. 184:1996;725-733.
27. Mauer A.M., Athens J.W., Ashenbrucker H., Cartwright G.E., Wintrobe M.M. Leukokinetic studies: II. A method for labelling granulocytes in vitro with radioactive diisopropylfluorophosphate (DFP-32). J. Clin. Invest. 39:1960;1481-1486.
28. McConkey D.J., Orrenius S., Jondal M. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J. Immunol. 145:1990;1227-1230.
29. McCord, J.M., 1992. Superoxide production and human disease. In: Jesaitis, A.J., Dratz, E.A. (Eds.), Molecular Basis of Oxidative Damage by Leukocytes, CRC, Boca Raton, FL, 225-239.
30. Messmer U.K., Ankarcrona M., Nicotera P., Brune B. p53 Expression in nitric oxide-induced apoptosis. FEBS Lett. 355:1994;23-26.
31. Messmer U.K., Lapetina E.G., Brune B. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol. Pharmacol. 47:1995;757-765.
32. Muhl H., Nitsch D., Sandau K., Brune B., Varga Z., Pfeilschifter J. Apoptosis is triggered by the cAMP signalling pathway in renal mesangial cells. FEBS Lett. 382:1996;271-275.
33. Murray J., Barbara J.A., Dunkley S.A., Lopez A.F., Van Ostade X., Condliffe A.M., Dransfield I., Haslett C., Chilvers E.R. Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood. 90:1997;2772-2783.
34. Nathan C., Sanchez E. Tumor necrosis factor and CD11/CD18 (beta 2) integrins act synergistically to lower cAMP in human neutrophils. J. Cell Biol. 111:1990;2171-2181.
35. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A.et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
36. Nielson C.P., Vestal R.E., Sturm R.J., Heaslip R. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J. Allergy Clin. Immunol. 86:1990;801-808.
37. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 233:1986;305-312.
38. Niwa M., Kohno K., Al-Essa L.Y., Kobayashi M., Nozaki M., Tsurumi K. Ibudilast, an anti-allergic and cerebral vasodilator, modulates superoxide production in human neutrophils. Life Sci. 56:1995;107-115.
39. Niwa M., Al-Essa L.Y., Kohno K., Kanamori Y., Matsuno M., Abe A., Uematsu T. The loss of rhGCSF and rhTNF-α priming effects on superoxide-generating response in exudated neutrophils is associated with decrease of their receptors affinities. J. Immunol. 157:1996;4147-4153.
40. Niwa M., Hara A., Kanamori Y., Yoshimi N., Mori H., Uematsu T. Comparison of susceptibility to apoptosis induced by rhTNF-α and cycloheximide between human circulating and exudated neutrophils. Life Sci. 61:1997;205-215.
41. Obeid L.M., Linardic C.M., Karolak L.A., Hannun Y.A. Programmed cell death induced by ceramide. Science. 259:1993;1769-1771.
42. Ottonello L., Gonella R., Dapino P., Sacchetti C., Dallegri F. Prostaglandin E2 inhibits apoptosis in human neutrophilic polymorphonuclear leukocytes: role of intracellular cyclic AMP levels. Exp. Hematol. 26:1998;895-902.
43. Parvathenani L.K., Buescher E.S., Chacon-Cruz E., Beebe S.J. Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils at a site upstream of caspase-3. J. Biol. Chem. 273:1998;6736-6743.
44. Rensing-Ehl A., Hess S., Ziegler-Heitbrock H.W., Riethmuller G., Engelmann H. Fas/Apo-1 activates nuclear factor kappa B and induces interleukin-6 production. J. Inflamm. 45:1995;161-174.
45. Rossi A.G., Cousin J.M., Dransfield I., Lawson M.F., Chilvers E.R., Haslett C. Agents that elevate cAMP inhibit human neutrophil apoptosis. Biochem. Biophys. Res. Commun. 217:1995;892-899.
46. Sakuta H., Inaba K., Muramatsu S. Calcitonin gene-related peptide enhances apoptosis of thymocytes. J. Neuroimmunol. 67:1996;103-109.
47. Savill J.S., Wyllie A.H., Henson J.E., Walport M.J., Henson P.M., Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83:1989;865-875.
48. Shi Y.F., Sahai B.M., Green D.R. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature. 339:1989;625-626.
49. Shimaoka M., Iida T., Ohara A., Taenaka N., Mashimo T., Honda T., Yoshiya I. NOC, a nitric-oxide-releasing compound, induces dose dependent apoptosis in macrophages. Biochem. Biophys. Res. Commun. 209:1995;519-526.
50. Simchowitz L., Fischbein L.C., Spilberg I., Atkinson J.P. Induction of a transient elevation in intracellular levels of adenosine-3′,5′-cyclic monophosphate by chemotactic factors: an early event in human neutrophil activation. J. Immunol. 124:1980;1482-1491.
51. Takeda Y., Watanabe H., Yonehara S., Yamashita T., Saito S., Sendo F. Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-alpha. Int. Immunol. 5:1993;691-694.
52. Tracey K.J., Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45:1994;491-503.
53. Tsuchida H., Takeda Y., Takei H., Shunzawa H., Takahashi T., Sendo F. In vivo regulation of rat neutrophil apoptosis occurring spontaneously or induced with TNF-α or cycloheximide. J. Immunol. 154:1995;2403-2412.
54. Tyagi S.R., Olson S.C., Burnham D.N., Lambeth J.D. Cyclic AMP-elevating agents block chemoattractant activation of diradylglycerol generation by inhibiting phospholipase D activation. J. Biol. Chem. 266:1991;3498-3504.
55. Volker T.T., Viratelle O.M., Delaage M.A., Labouesse J. Radioimmunoassay of cyclic AMP can provide a highly sensitive assay for adenylate cyclase, even at very high ATP concentrations. Anal. Biochem. 144:1985;347-355.
56. Whyte M.K., Meagher L.C., MacDermot J., Haslett C. Impairment of function in aging neutrophils is associated with apoptosis. J. Immunol. 150:1993;5124-5134.
57. Whyte M.K., Savill J., Meagher L.C., Lee A., Haslett C. Coupling of neutrophil apoptosis to recognition by macrophages. J. Leukoc. Biol. 62:1997;195-202.
58. Wong G.H., Goeddel D.V. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science. 242:1988;941-944.